Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q87130967
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241120235942.0 |
008
|
|
|
241120nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q87130967
|
024
|
|
|
‡a
0000-0001-6125-5486
‡2
orcid
|
024
|
|
|
‡a
55820663800
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q87130967
|
100
|
0 |
|
‡a
Sara Vaz-Pereira
‡c
researcher
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
S Vaz-Pereira
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's Diabetic eye disease
|
670
|
|
|
‡a
Author's Evaluación multimodal de la malformación arteriovenosa de la retina en el síndrome de Wyburn-Mason
|
670
|
|
|
‡a
Author's Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases
|
670
|
|
|
‡a
Author's Implantation pearl cyst after uncomplicated clear cornea phacoemulsification mimicking an iris tumour.
|
670
|
|
|
‡a
Author's Intravitreal aflibercept for choroidal neovascularisation in angioid streaks
|
670
|
|
|
‡a
Author's Macular dystrophy presenting in one of two siblings with limb-girdle muscular dystrophy type 2L due to mutation of ANO5.
|
670
|
|
|
‡a
Author's Multicolor imaging in the diagnosis and follow up of type 2 acute macular neuroretinopathy
|
670
|
|
|
‡a
Author's Multimodal imaging of exudative maculopathy associated with hand-foot-mouth disease.
|
670
|
|
|
‡a
Author's Multimodal Imaging of Subhyaloid Hemorrhage in Valsalva Retinopathy Treated with Nd:YAG Laser
|
670
|
|
|
‡a
Author's Near-infrared reflectance imaging of neovascularization in proliferative diabetic retinopathy
|
670
|
|
|
‡a
Author's Optical Coherence Tomography Angiography Features of Neovascularization in Proliferative Diabetic Retinopathy
|
670
|
|
|
‡a
Author's Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review
|
670
|
|
|
‡a
Author's Proliferative diabetic retinopathy imaged by near-infrared reflectance
|
670
|
|
|
‡a
Author's Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.
|
670
|
|
|
‡a
Author's Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy.
|
670
|
|
|
‡a
Author's Spectral-Domain Optical Coherence Tomography of Polypoidal Choroidal Vasculopathy Associated With Benign Choroidal Nevus
|
670
|
|
|
‡a
Author's The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema
|
670
|
|
|
‡a
Author's The Portuguese Experience with Ocriplasmin in Clinical Practice.
|
670
|
|
|
‡a
Author's Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives.
|
670
|
|
|
‡a
Author's VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters
|
909
|
|
|
‡a
(orcid) 0000000161255486
‡9
1
|
909
|
|
|
‡a
(scopus) 55820663800
‡9
1
|
919
|
|
|
‡a
diabeticeyedisease
‡A
Diabetic eye disease
‡9
1
|
919
|
|
|
‡a
vegfblevelsinthevitreousofdiabeticandnondiabeticpatientswithoculardiseasesanditscorrelationwithstructuralparameters
‡A
VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters
‡9
1
|
919
|
|
|
‡a
vascularendothelialgrowthfactorsandplacentagrowthfactorinretinalvasculopathiescurrentresearchandfutureperspectives
‡A
Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives.
‡9
1
|
919
|
|
|
‡a
portugueseexperiencewithocriplasmininclinicalpractice
‡A
The Portuguese Experience with Ocriplasmin in Clinical Practice.
‡9
1
|
919
|
|
|
‡a
outcomesofswitchingfromshorttolongtermintravitrealcorticosteroidimplanttherapyinpatientswithdiabeticmacularedema
‡A
The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema
‡9
1
|
919
|
|
|
‡a
spectraldomainopticalcoherencetomographyofpolypoidalchoroidalvasculopathyassociatedwithbenignchoroidalnevus
‡A
Spectral-Domain Optical Coherence Tomography of Polypoidal Choroidal Vasculopathy Associated With Benign Choroidal Nevus
‡9
1
|
919
|
|
|
‡a
sensitivityandspecificityofspectraldomainopticalcoherencetomographyindetectingidiopathicpolypoidalchoroidalvasculopathy
‡A
Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy.
‡9
1
|
919
|
|
|
‡a
realworldoutcomesofantivegftreatmentforretinalveinocclusioninportugal
‡A
Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal.
‡9
1
|
919
|
|
|
‡a
proliferativediabeticretinopathyimagedbynearinfraredreflectance
‡A
Proliferative diabetic retinopathy imaged by near-infrared reflectance
‡9
1
|
919
|
|
|
‡a
opticalcoherencetomographyfeaturesofneovascularizationinproliferativediabeticretinopathyasystematicreview
‡A
Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review
‡9
1
|
919
|
|
|
‡a
opticalcoherencetomographyangiographyfeaturesofneovascularizationinproliferativediabeticretinopathy
‡A
Optical Coherence Tomography Angiography Features of Neovascularization in Proliferative Diabetic Retinopathy
‡9
1
|
919
|
|
|
‡a
nearinfraredreflectanceimagingofneovascularizationinproliferativediabeticretinopathy
‡A
Near-infrared reflectance imaging of neovascularization in proliferative diabetic retinopathy
‡9
1
|
919
|
|
|
‡a
multimodalimagingofsubhyaloidhemorrhageinvalsalvaretinopathytreatedwithndyaglaser
‡A
Multimodal Imaging of Subhyaloid Hemorrhage in Valsalva Retinopathy Treated with Nd:YAG Laser
‡9
1
|
919
|
|
|
‡a
multimodalimagingofexudativemaculopathyassociatedwithhandfootmouthdisease
‡A
Multimodal imaging of exudative maculopathy associated with hand-foot-mouth disease.
‡9
1
|
919
|
|
|
‡a
multicolorimaginginthediagnosisandfollowupoftype2acutemacularneuroretinopathy
‡A
Multicolor imaging in the diagnosis and follow up of type 2 acute macular neuroretinopathy
‡9
1
|
919
|
|
|
‡a
maculardystrophypresentingin1of2siblingswithlimbgirdlemusculardystrophytype2lduetomutationofano5
‡A
Macular dystrophy presenting in one of two siblings with limb-girdle muscular dystrophy type 2L due to mutation of ANO5.
‡9
1
|
919
|
|
|
‡a
intravitrealafliberceptforchoroidalneovascularisationinangioidstreaks
‡A
Intravitreal aflibercept for choroidal neovascularisation in angioid streaks
‡9
1
|
919
|
|
|
‡a
implantationpearlcystafteruncomplicatedclearcorneaphacoemulsificationmimickinganiristumour
‡A
Implantation pearl cyst after uncomplicated clear cornea phacoemulsification mimicking an iris tumour.
‡9
1
|
919
|
|
|
‡a
evaluationofthegrowthfactorsvegfaandvegfbinthevitreousandserumofpatientswithmacularandretinalvasculardiseases
‡A
Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases
‡9
1
|
919
|
|
|
‡a
evaluacionmultimodaldelamalformacionarteriovenosadelaretinaenelsindromedewyburnmason
‡A
Evaluación multimodal de la malformación arteriovenosa de la retina en el síndrome de Wyburn-Mason
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
ISNI|0000000381996438
|
996
|
|
|
‡2
LC|n 85123561
|
996
|
|
|
‡2
LC|n 82030442
|
996
|
|
|
‡2
LC|n 00031455
|
996
|
|
|
‡2
ISNI|0000000024428264
|
996
|
|
|
‡2
DNB|1053080115
|
996
|
|
|
‡2
PLWABN|9810673007305606
|
996
|
|
|
‡2
BIBSYS|8083618
|
996
|
|
|
‡2
ISNI|0000000070541217
|
996
|
|
|
‡2
SUDOC|179015184
|
996
|
|
|
‡2
PTBNP|1583019
|
996
|
|
|
‡2
SUDOC|145601463
|
996
|
|
|
‡2
PTBNP|1523675
|
996
|
|
|
‡2
SUDOC|26088233X
|
996
|
|
|
‡2
PTBNP|262023
|
996
|
|
|
‡2
PTBNP|1849131
|
996
|
|
|
‡2
LC|no 96021045
|
996
|
|
|
‡2
PTBNP|1254045
|
996
|
|
|
‡2
PTBNP|1450369
|
996
|
|
|
‡2
ISNI|0000000068011874
|
996
|
|
|
‡2
NKC|xx0161106
|
996
|
|
|
‡2
SUDOC|17653301X
|
996
|
|
|
‡2
SUDOC|271184744
|
996
|
|
|
‡2
PTBNP|1871712
|
996
|
|
|
‡2
LC|no2023064980
|
996
|
|
|
‡2
LC|no2011112550
|
996
|
|
|
‡2
PTBNP|1900154
|
996
|
|
|
‡2
PTBNP|1875931
|
996
|
|
|
‡2
DNB|1184318514
|
996
|
|
|
‡2
LC|n 78095905
|
996
|
|
|
‡2
RERO|A023659177
|
996
|
|
|
‡2
RERO|A027405959
|
996
|
|
|
‡2
BNE|XX1555724
|
996
|
|
|
‡2
ISNI|0000000026817837
|
996
|
|
|
‡2
BNCHL|10000000000000000046828
|
996
|
|
|
‡2
LC|no2012124192
|
996
|
|
|
‡2
PTBNP|948977
|
996
|
|
|
‡2
SUDOC|186269900
|
996
|
|
|
‡2
PTBNP|997762
|
996
|
|
|
‡2
ISNI|0000000068602420
|
996
|
|
|
‡2
PTBNP|1872730
|
996
|
|
|
‡2
PTBNP|810640
|
996
|
|
|
‡2
BNF|14606317
|
996
|
|
|
‡2
NSK|000637968
|
996
|
|
|
‡2
PTBNP|1887683
|
996
|
|
|
‡2
BNF|16010239
|
996
|
|
|
‡2
BLBNB|001589794
|
996
|
|
|
‡2
LC|no2016075017
|
996
|
|
|
‡2
ISNI|0000000428267831
|
996
|
|
|
‡2
PTBNP|1788627
|
996
|
|
|
‡2
PTBNP|1509748
|
996
|
|
|
‡2
ISNI|0000000070709497
|
996
|
|
|
‡2
SUDOC|11398684X
|
996
|
|
|
‡2
PTBNP|1232723
|
996
|
|
|
‡2
PTBNP|1850970
|
996
|
|
|
‡2
PTBNP|698106
|
996
|
|
|
‡2
SUDOC|073360910
|
996
|
|
|
‡2
ISNI|0000000078144937
|
996
|
|
|
‡2
PTBNP|1876089
|
996
|
|
|
‡2
PTBNP|1477027
|
996
|
|
|
‡2
PTBNP|1890530
|
996
|
|
|
‡2
DNB|1056297786
|
996
|
|
|
‡2
PTBNP|1780361
|
996
|
|
|
‡2
PTBNP|1369472
|
996
|
|
|
‡2
PTBNP|1811223
|
996
|
|
|
‡2
ISNI|0000000070327368
|
996
|
|
|
‡2
SUDOC|277260477
|
996
|
|
|
‡2
PTBNP|1476527
|
996
|
|
|
‡2
BNF|15071288
|
996
|
|
|
‡2
ISNI|0000000428260314
|
996
|
|
|
‡2
PTBNP|1417313
|
996
|
|
|
‡2
DBC|87097939142252
|
996
|
|
|
‡2
LIH|LNB:CX_q_8;=B_q_
|
996
|
|
|
‡2
RERO|A027646937
|
996
|
|
|
‡2
ISNI|0000000066371438
|
996
|
|
|
‡2
PTBNP|196196
|
996
|
|
|
‡2
ISNI|0000000043637627
|
996
|
|
|
‡2
PTBNP|1571567
|
996
|
|
|
‡2
ISNI|0000000068090656
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|